Novartis CEO stands by emerging markets even as China economy continues to weaken

Eric Palmer

's is a mess and other are flailing about as well. So what is pharma CEO to do if they have bet big on growth in the EM realm? Keep on keeping on, says CEO Joe Jimenez.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS